[用于预防儿童期感染的新型15价肺炎球菌结合疫苗：一项卫生技术评估] - Suppr

[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].

作者信息

Calabrò Giovanna Elisa, Vitale Francesco, Rizzo Caterina, Pugliese Andrea, Boccalini Sara, Bechini Angela, Panatto Donatella, Amicizia Daniela, Domnich Alexander, Amodio Emanuele, Costantino Claudio, DI Pietro Maria Luisa, Salvati Cristina, D'Ambrosio Floriana, Orsini Francesca, Maida Ada, Dominici Anna, Clemente Dania, Cecci Marina, Pellacchia Andrea, DI Serafino Francesca, Bakker Kevin, Malik Tufail Mohammad, Sharomi Oluwaseun, Belluzzo Miriam, Leonforte Francesco, Zagra Luigi, LA Gatta Emanuele, Petrella Luigi, Bonanni Paolo, DE Waure Chiara

机构信息

Sezione di Igiene, Dipartimento Universitario di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italia.

VIHTALI (Value In Health Technology and Academy for Leadership & Innovation), Spin-off dell'Università Cattolica del Sacro Cuore, Roma, Italia.

出版信息

J Prev Med Hyg. 2023 Jun 29;64(1 Suppl 1):E1-E160. doi: 10.15167/2421-4248/jpmh2023.64.1s1. eCollection 2023 Mar.

DOI:10.15167/2421-4248/jpmh2023.64.1s1

PMID:37655211

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10468156/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/10468156/bea7edf13f5e/jpmh-2023-01-S1-g006.jpg

相似文献

[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].[用于预防儿童期感染的新型15价肺炎球菌结合疫苗：一项卫生技术评估]

J Prev Med Hyg. 2023 Jun 29;64(1 Suppl 1):E1-E160. doi: 10.15167/2421-4248/jpmh2023.64.1s1. eCollection 2023 Mar.

20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.20价肺炎球菌结合疫苗：成人使用情况综述

Drugs. 2022 Jun;82(9):989-999. doi: 10.1007/s40265-022-01733-z. Epub 2022 Jul 6.

Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan.日本引入 13 价肺炎球菌结合疫苗后儿童肺炎球菌性脑膜炎的临床和细菌学分析。

Microbiol Spectr. 2022 Apr 27;10(2):e0182221. doi: 10.1128/spectrum.01822-21. Epub 2022 Mar 31.

[Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].[成人肺炎链球菌（肺炎球菌）感染的预防]

Orv Hetil. 2014 Dec 14;155(50):1996-2004. doi: 10.1556/OH.2014.30070.

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.葡萄牙 2010-2015 年 13 价肺炎球菌结合疫苗接种者中由 3 型肺炎链球菌引起的儿童复杂性肺炎。

Emerg Infect Dis. 2018 Jul;24(7):1307-1314. doi: 10.3201/eid2407.180029.

[Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia].[两例未接种疫苗儿童的侵袭性肺炎球菌疾病：胸膜脓胸和菌血症]

Mikrobiyol Bul. 2015 Jul;49(3):446-53. doi: 10.5578/mb.9742.

Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.美国≥50 岁社区获得性肺炎成人中 13 价肺炎球菌结合疫苗血清型的分布。

J Infect Dis. 2013 Dec 1;208(11):1813-20. doi: 10.1093/infdis/jit506. Epub 2013 Oct 2.

Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study.13 价肺炎球菌结合疫苗在中国儿童中的疫苗血清型社区获得性肺炎球菌病的有效性：一项病例对照研究。

Vaccine. 2024 Feb 27;42(6):1275-1282. doi: 10.1016/j.vaccine.2024.01.068. Epub 2024 Jan 30.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.在未接种过肺炎球菌疫苗的成年人中，13价肺炎球菌结合疫苗与23价肺炎球菌多糖疫苗的免疫原性和安全性比较

Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18.

Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.哮喘儿童和青少年中的肺炎链球菌定植：七价肺炎球菌结合疫苗的影响及十三价肺炎球菌结合疫苗潜在效果的评估

BMC Infect Dis. 2016 Jan 12;16:12. doi: 10.1186/s12879-016-1335-3.

引用本文的文献

Health Technology Assessment of Vaccines in Italy: History and Review of Applications.意大利疫苗的卫生技术评估：历史与应用综述

Vaccines (Basel). 2024 Sep 24;12(10):1090. doi: 10.3390/vaccines12101090.

本文引用的文献

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).一项评价 V114（一种 15 价肺炎球菌结合疫苗）在异基因造血细胞移植受者中的安全性、耐受性和免疫原性的 3 期、随机、双盲、对照研究（PNEU-STEM）。

Clin Infect Dis. 2023 Oct 13;77(8):1102-1110. doi: 10.1093/cid/ciad349.

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 33 种细菌病原体相关的全球死亡率：2019 年全球疾病负担研究的系统分析。

Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21.

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data.利用免疫原性数据预测儿童侵袭性肺炎球菌疾病疫苗的有效性。

NPJ Vaccines. 2022 Nov 7;7(1):140. doi: 10.1038/s41541-022-00538-1.

The remarkable history of pneumococcal vaccination: an ongoing challenge.肺炎球菌疫苗的非凡历史：一项持续的挑战。

Pneumonia (Nathan). 2022 Sep 25;14(1):5. doi: 10.1186/s41479-022-00097-y.

A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN).一项 III 期、多中心、随机、双盲、阳性对照对照研究，旨在评估 15 价肺炎球菌结合疫苗 V114 在健康婴儿、儿童和青少年中的追赶接种方案的安全性、耐受性和免疫原性（PNEU-PLAN）。

Vaccine. 2022 Oct 19;40(44):6315-6325. doi: 10.1016/j.vaccine.2022.09.003. Epub 2022 Sep 21.

Incidence of Hospitalisation and Emergency Department Visits for Pneumococcal Disease in Children, Adolescents, and Adults in Liguria, Italy: A Retrospective Analysis from 2012-2018.意大利利古里亚地区儿童、青少年和成人肺炎球菌疾病住院及急诊就诊发生率：2012 - 2018年回顾性分析

Vaccines (Basel). 2022 Aug 24;10(9):1375. doi: 10.3390/vaccines10091375.

The Economic Burden of Pneumococcal Disease in Children: A Population-Based Investigation in the Veneto Region of Italy.儿童肺炎球菌疾病的经济负担：意大利威尼托地区的一项基于人群的调查。

Children (Basel). 2022 Sep 3;9(9):1347. doi: 10.3390/children9091347.

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial.15 价肺炎球菌结合疫苗的安全性：一项 I 期临床试验。

Hum Vaccin Immunother. 2022 Nov 30;18(6):2116881. doi: 10.1080/21645515.2022.2116881. Epub 2022 Sep 19.

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.美国儿童使用 15 价肺炎球菌结合疫苗：免疫实践咨询委员会更新建议-美国，2022 年。

MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1174-1181. doi: 10.15585/mmwr.mm7137a3.

Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children.预测V114疫苗对儿童侵袭性肺炎球菌疾病的有效性。

Expert Rev Vaccines. 2022 Oct;21(10):1515-1521. doi: 10.1080/14760584.2022.2112179. Epub 2022 Aug 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献